These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 22539346)

  • 1. Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.
    Xiao Q; Gil SC; Yan P; Wang Y; Han S; Gonzales E; Perez R; Cirrito JR; Lee JM
    J Biol Chem; 2012 Jun; 287(25):21279-89. PubMed ID: 22539346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of PTB domain containing adaptor proteins on PICALM-mediated APP endocytosis and localization.
    Merthan L; Haller A; Thal DR; von Einem B; von Arnim CAF
    Biochem J; 2019 Jul; 476(14):2093-2109. PubMed ID: 31300465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer's disease.
    Thomas RS; Henson A; Gerrish A; Jones L; Williams J; Kidd EJ
    BMC Neurosci; 2016 Jul; 17(1):50. PubMed ID: 27430330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.
    Tian Y; Chang JC; Fan EY; Flajolet M; Greengard P
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17071-6. PubMed ID: 24067654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis.
    Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Tripoli DL; Czerniewski L; Ballabio A; Cirrito JR; Diwan A; Lee JM
    J Neurosci; 2015 Sep; 35(35):12137-51. PubMed ID: 26338325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PICALM and Alzheimer's Disease: An Update and Perspectives.
    Ando K; Nagaraj S; Küçükali F; de Fisenne MA; Kosa AC; Doeraene E; Lopez Gutierrez L; Brion JP; Leroy K
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High glucose-mediated PICALM and mTORC1 modulate processing of amyloid precursor protein via endosomal abnormalities.
    Chae CW; Lee HJ; Choi GE; Jung YH; Kim JS; Lim JR; Kim SY; Hwang IK; Seong JK; Han HJ
    Br J Pharmacol; 2020 Aug; 177(16):3828-3847. PubMed ID: 32436237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and expression of picalm in Alzheimer disease.
    Baig S; Joseph SA; Tayler H; Abraham R; Owen MJ; Williams J; Kehoe PG; Love S
    J Neuropathol Exp Neurol; 2010 Oct; 69(10):1071-7. PubMed ID: 20838239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic processing of Alzheimer's β-amyloid precursor protein.
    Zhang H; Ma Q; Zhang YW; Xu H
    J Neurochem; 2012 Jan; 120 Suppl 1(Suppl 1):9-21. PubMed ID: 22122372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
    Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
    Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
    Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
    J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clathrin-mediated endocytic proteins are upregulated in the cortex of the Tg2576 mouse model of Alzheimer's disease-like amyloid pathology.
    Thomas RS; Lelos MJ; Good MA; Kidd EJ
    Biochem Biophys Res Commun; 2011 Dec; 415(4):656-61. PubMed ID: 22079091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions.
    van Groen T; Liu L; Ikonen S; Kadish I
    Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition.
    Chakrabarty P; Tianbai L; Herring A; Ceballos-Diaz C; Das P; Golde TE
    Mol Neurodegener; 2012 Jul; 7():36. PubMed ID: 22838967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fimbria-fornix lesion does not affect APP levels and amyloid deposition in the hippocampus of APP+PS1 double transgenic mice.
    Liu L; Ikonen S; Tapiola T; Tanila H; van Groen T
    Exp Neurol; 2002 Oct; 177(2):565-74. PubMed ID: 12429202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.
    Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F
    J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteins Involved in Endocytosis Are Upregulated by Ageing in the Normal Human Brain: Implications for the Development of Alzheimer's Disease.
    Alsaqati M; Thomas RS; Kidd EJ
    J Gerontol A Biol Sci Med Sci; 2018 Mar; 73(3):289-298. PubMed ID: 28655199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.